Nabriva Therapeutics plc Restricted Cash
Nabriva Therapeutics plc had Restricted Cash of $73.00 thousand as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-10-19
- 2023-06-30: Restricted Cash $73.00K.
- 2023-03-31: Restricted Cash $123.00K.
- 2022-12-31: Restricted Cash $123.00K.
- 2022-09-30: Restricted Cash $121.00K.
| Period end | Restricted Cash |
|---|---|
| 2023-06-30 | $73.00K 10-Q · filed 2023-10-19 |
| 2023-03-31 | $123.00K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $123.00K 10-Q · filed 2023-10-19 |
| 2022-09-30 | $121.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $122.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $174.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $175.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $179.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $180.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $230.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $231.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $230.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $229.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $444.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $392.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $228.00K 10-Q · filed 2019-11-12 |